MAP-AD Test Oligos - Oligo2-Rev
MAP-AD Test Oligos
IVD Class CIVDR 2017/746On the marketProfessional testingReagent
- Manufacturer
- ADmit Therapeutics
- Manufacturer SRN
- ES-MF-000042518
- UDI-DI
- 08437026887049
- Basic UDI-DI
- 8437026887AD001YH
- Reference
- AD001-04
- EMDN
- W0106010201
- EMDN description
- ALZHEIMER'S DISEASE
- First on market country
- Spain
- Authorised representative
- -
- Last updated
- 30.06.2026 15:37